Patient Information

Possible simeprevir/sofosbuvir-induced hepatic decompensation with acute kidney failure


 

References

In this case report, the authors describe their experience in caring for a 62-year-old man with hepatic decompensation and acute kidney injury that was caused by simeprevir/sofosbuvir initiation for chronic hepatitis C (HCV). In the article, which is available at http://www.fedprac.com/the-publication/issue-single-view/possible-simeprevirsofosbuvir-induced-hepatic-decompensation-with-acute-kidney-failure/4aa123f84bba6831d73a86fd67565a5e/ocregister.html, the authors advise that careful consideration is needed prior to the initiation of simeprevir/sofosbuvir—particularly in patients with advanced liver disease or known hepatocellular carcinoma and baseline renal impairment.

Recommended Reading

Report laid groundwork for ending the public health problem of viral hepatitis
MDedge Family Medicine
Study: Few HCV-infected heroin users linked to outpatient care
MDedge Family Medicine
Fibrosis still key to predicting NAFLD mortality
MDedge Family Medicine
New hope for primary sclerosing cholangitis treatment
MDedge Family Medicine
Biliary inflammation reduced by IBD drug
MDedge Family Medicine
Investigational HBV core inhibitor shows early clinical promise
MDedge Family Medicine
Risk stratification for progression of primary biliary cholangitis at diagnosis
MDedge Family Medicine
Hepatitis B test identifies active carriers
MDedge Family Medicine
Large placebo effect seen in trial of maralixibat for primary biliary cholangitis
MDedge Family Medicine
Algorithm predicts late liver disease ICU benefit
MDedge Family Medicine